Back to 
HBK INVESTMENTS L P
HBK INVESTMENTS L P
ALXNShowing 0 of 6 quarters
Position history for HBK INVESTMENTS L P's holdings in ALEXION PHARMACEUTICALS INC
As of its Q2 2021 13F, HBK Investments held 6,600,000 shares of ALXN (Alexion Pharmaceuticals), worth $1.2B. HBK Investments' 13F filings listed ALXN from Q4 2020 to Q2 2021, 3 quarterly filings. ALXN was 4.3% of HBK Investments' reported 13F portfolio.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ALXN: FMR LLC, STATE STREET CORP